Michael G. Kauffman

2013

In 2013, Michael G. Kauffman earned a total compensation of $7.3M as Chief Executive Officer at Karyopharm Therapeutics, a 1,483% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$170,000
Option Awards$6,771,948
Salary$380,507
Other$10,258
Total$7,332,713

Kauffman received $6.8M in option awards, accounting for 92% of the total pay in 2013.

Kauffman also received $170K in non-equity incentive plan, $380.5K in salary and $10.3K in other compensation.

Rankings

In 2013, Michael G. Kauffman's compensation ranked 739th out of 12,286 executives tracked by ExecPay. In other words, Kauffman earned more than 94.0% of executives.

ClassificationRankingPercentile
All
739
out of 12,286
94th
Division
Manufacturing
240
out of 4,612
95th
Major group
Chemicals And Allied Products
65
out of 1,462
96th
Industry group
Drugs
40
out of 1,156
97th
Industry
Pharmaceutical Preparations
36
out of 890
96th
Source: SEC filing on April 7, 2015.

Kauffman's colleagues

We found two more compensation records of executives who worked with Michael G. Kauffman at Karyopharm Therapeutics in 2013.

2013

Sharon Shacham

Karyopharm Therapeutics

Chief Scientific Officer

2013

Paul Brannelly

Karyopharm Therapeutics

Senior Vice President, Finance and Administration

News

In-depth

You may also like